Cargando…

Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru

BACKGROUND: Peru holds the fourth highest burden of tuberculosis in the Americas. Despite an apparently well-functioning DOTS control program, the prevalence of multidrug resistant tuberculosis (MDR-TB) continues to increase. To worsen this situation, cases of extensively drug resistance tuberculosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cáceres, Omar, Rastogi, Nalin, Bartra, Carlos, Couvin, David, Galarza, Marco, Asencios, Luis, Mendoza-Ticona, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260790/
https://www.ncbi.nlm.nih.gov/pubmed/25489950
http://dx.doi.org/10.1371/journal.pone.0112789
_version_ 1782348225460568064
author Cáceres, Omar
Rastogi, Nalin
Bartra, Carlos
Couvin, David
Galarza, Marco
Asencios, Luis
Mendoza-Ticona, Alberto
author_facet Cáceres, Omar
Rastogi, Nalin
Bartra, Carlos
Couvin, David
Galarza, Marco
Asencios, Luis
Mendoza-Ticona, Alberto
author_sort Cáceres, Omar
collection PubMed
description BACKGROUND: Peru holds the fourth highest burden of tuberculosis in the Americas. Despite an apparently well-functioning DOTS control program, the prevalence of multidrug resistant tuberculosis (MDR-TB) continues to increase. To worsen this situation, cases of extensively drug resistance tuberculosis (XDR-TB) have been detected. Little information exists about the genetic diversity of drug-susceptible vs. MDR-TB and XDR-TB. METHODS: Cryopreserved samples of XDR strains from 2007 to 2009 (second semester), were identified and collected. Starting from 227 frozen samples, a total of 142 XDR-TB strains of Mycobacterium tuberculosis complex (MTBC; 1 isolate per patient) were retained for this study. Each strain DNA was analyzed by spoligotyping and the 15-loci Mycobacterial Interspersed Repetitive Unit (MIRU-15). RESULTS: Among the 142 isolates analyzed, only 2 samples (1.41%) could not be matched to any lineage. The most prevalent sublineage was Haarlem (43.66%), followed by T (27.46%), LAM (16.2%), Beijing (9.15%), and X clade (1.41%). Spoligotype analysis identified clustering for 128/142 (90.1%) isolates vs. 49/142 (34.5%) with MIRUs. Of the samples, 90.85% belonged to retreated patients. The drug resistant profile demonstrated that 62.67% showed resistance to injectable drugs capreomycin (CAP) and kanamycin (KAN) vs. 15.5% to CAP alone and 21.8% to KAN alone. The SIT219/T1 and SIT50/H3 were the most prevalent patterns in our study. The spoligoforest analysis showed that SIT53/T1 was at the origin of many of the T lineage strains as well as a big proportion of Haarlem lineage strains (SIT50/H3, followed by SIT47/H1, SIT49/H3, and SIT2375/H1), as opposed to the SIT1/Beijing strains that did not appear to evolve into minor Beijing sublineages among the XDR-TB strains. CONCLUSION: In contrast with other Latin-American countries where LAM sublineage is the most predominant, we found the Haarlem to be the most common followed by T sublineage among the XDR-TB strains.
format Online
Article
Text
id pubmed-4260790
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42607902014-12-15 Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru Cáceres, Omar Rastogi, Nalin Bartra, Carlos Couvin, David Galarza, Marco Asencios, Luis Mendoza-Ticona, Alberto PLoS One Research Article BACKGROUND: Peru holds the fourth highest burden of tuberculosis in the Americas. Despite an apparently well-functioning DOTS control program, the prevalence of multidrug resistant tuberculosis (MDR-TB) continues to increase. To worsen this situation, cases of extensively drug resistance tuberculosis (XDR-TB) have been detected. Little information exists about the genetic diversity of drug-susceptible vs. MDR-TB and XDR-TB. METHODS: Cryopreserved samples of XDR strains from 2007 to 2009 (second semester), were identified and collected. Starting from 227 frozen samples, a total of 142 XDR-TB strains of Mycobacterium tuberculosis complex (MTBC; 1 isolate per patient) were retained for this study. Each strain DNA was analyzed by spoligotyping and the 15-loci Mycobacterial Interspersed Repetitive Unit (MIRU-15). RESULTS: Among the 142 isolates analyzed, only 2 samples (1.41%) could not be matched to any lineage. The most prevalent sublineage was Haarlem (43.66%), followed by T (27.46%), LAM (16.2%), Beijing (9.15%), and X clade (1.41%). Spoligotype analysis identified clustering for 128/142 (90.1%) isolates vs. 49/142 (34.5%) with MIRUs. Of the samples, 90.85% belonged to retreated patients. The drug resistant profile demonstrated that 62.67% showed resistance to injectable drugs capreomycin (CAP) and kanamycin (KAN) vs. 15.5% to CAP alone and 21.8% to KAN alone. The SIT219/T1 and SIT50/H3 were the most prevalent patterns in our study. The spoligoforest analysis showed that SIT53/T1 was at the origin of many of the T lineage strains as well as a big proportion of Haarlem lineage strains (SIT50/H3, followed by SIT47/H1, SIT49/H3, and SIT2375/H1), as opposed to the SIT1/Beijing strains that did not appear to evolve into minor Beijing sublineages among the XDR-TB strains. CONCLUSION: In contrast with other Latin-American countries where LAM sublineage is the most predominant, we found the Haarlem to be the most common followed by T sublineage among the XDR-TB strains. Public Library of Science 2014-12-09 /pmc/articles/PMC4260790/ /pubmed/25489950 http://dx.doi.org/10.1371/journal.pone.0112789 Text en © 2014 Cβceres et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Cáceres, Omar
Rastogi, Nalin
Bartra, Carlos
Couvin, David
Galarza, Marco
Asencios, Luis
Mendoza-Ticona, Alberto
Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru
title Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru
title_full Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru
title_fullStr Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru
title_full_unstemmed Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru
title_short Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru
title_sort characterization of the genetic diversity of extensively-drug resistant mycobacterium tuberculosis clinical isolates from pulmonary tuberculosis patients in peru
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260790/
https://www.ncbi.nlm.nih.gov/pubmed/25489950
http://dx.doi.org/10.1371/journal.pone.0112789
work_keys_str_mv AT caceresomar characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu
AT rastoginalin characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu
AT bartracarlos characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu
AT couvindavid characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu
AT galarzamarco characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu
AT asenciosluis characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu
AT mendozaticonaalberto characterizationofthegeneticdiversityofextensivelydrugresistantmycobacteriumtuberculosisclinicalisolatesfrompulmonarytuberculosispatientsinperu